ArticleNature medicine2024
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Jeroen van Dorp et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it